Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-Positive AML.
Mol Cancer Ther. 2021 Nov;20(11):2207-2217. doi: 10.1158/1535-7163.MCT-21-0071. Epub 2021 Sep 13.
Mol Cancer Ther. 2021.
PMID: 34518298
Free PMC article.
TP-0903 is active in models of drug-resistant acute myeloid leukemia.
Jeon JY, Buelow DR, Garrison DA, Niu M, Eisenmann ED, Huang KM, Zavorka Thomas ME, Weber RH, Whatcott CJ, Warner SL, Orwick SJ, Carmichael B, Stahl E, Brinton LT, Lapalombella R, Blachly JS, Hertlein E, Byrd JC, Bhatnagar B, Baker SD.
Jeon JY, et al. Among authors: zavorka thomas me.
JCI Insight. 2020 Dec 3;5(23):e140169. doi: 10.1172/jci.insight.140169.
JCI Insight. 2020.
PMID: 33268594
Free PMC article.
Item in Clipboard
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia.
Zavorka Thomas ME, Jeon JY, Talebi Z, Buelow DR, Silvaroli J, Campbell MJ, Sparreboom A, Pabla N, Baker SD.
Zavorka Thomas ME, et al.
Blood Adv. 2021 Dec 14;5(23):5041-5046. doi: 10.1182/bloodadvances.2021005614.
Blood Adv. 2021.
PMID: 34614509
Free PMC article.
Item in Clipboard
Cite
Cite